Honors and Milestones
Mabpharm Limited with its outstanding technological R&D capabilities, has established itself as a leader in the biopharmaceutical field, earning numerous honors from cities, provinces, and the nation. The company is deeply committed to technological innovation and has independently developed several drugs, such as the EGFR antibody drug Enlituo®, which not only fills the gap in domestically developed products for related therapeutic areas, but also demonstrates its profound expertise in cutting-edge medical research, including cancer treatment. Supported by its technological R&D strength, Mabpharm Limited continues to push boundaries, setting new benchmarks for the industry.
At the same time, Mabpharm Limited actively fulfills its social responsibilities and has received social honors such as the "Youth Civilization Award" and the "High-level Innovative Talent" under the "113 Pharmaceutical Talent Special Plan," demonstrating the responsibility and spirit of youth in the new era. Mabpharm Limited closely integrates technological R&D with social benefits, embodying the responsibility and mission of a corporate citizen through practical actions. While promoting the development of the biopharmaceutical industry, it also contributes youthful energy to building a harmonious society, earning respect and praise from all sectors of society.
